HIGHLIGHTS
- who: Annalisa Lonetti from the Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy have published the Article: Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway, in the Journal: (JOURNAL)
- what: In this context a major contribution was provided by the introduction of the nucleoside analog nelarabine approved for salvage treatment of T-ALL patients with refractory/relapsed disease.
SUMMARY
To better understand the role of Bcl2 family, it was first investigated the gene_expression of Bcl2 and Bcl-xL genes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.